Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Illumina Advances Sequencing Overseas

by Ann M. Thayer
July 28, 2014 | A version of this story appeared in Volume 92, Issue 30

Illumina has signed two deals that will expand the use of its next-generation sequencing technology overseas. It is working with China’s Berry Genomics to develop an NGS system for noninvasive prenatal testing. A version of the system, which uses Illumina’s instrument and Berry’s assays and software, is in late-stage review with the Chinese FDA, the companies say. In Qatar, the new Sidra Medical & Research Center will house a high-throughput genomics center to conduct gene-sequencing and population studies for the Middle East and North Africa. It will use Illumina’s HiSeq X Ten system, initially to create an Arab reference genome to explore genetic variants in the population.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.